T lymphocytes derived from MS patients overexpress RANTES receptor CCR5 [27], and RANTES production is enhanced in peripheral blood mononuclear cells from patients with RRMS [28], and elevated RANTES CSF levels have been reported in relapsing patients [29]. This evidence concerns the gene CCR5 and myeloid sarcoma.